IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells.

The role of IGF binding protein 2 (IGFBP2) in cell growth is intriguing and largely undefined. Previously we identified IGFBP2 as an extrinsic factor that supports ex vivo expansion of hematopoietic stem cells (HSCs). Here we showed that IGFBP2-null mice have fewer HSCs than wild-type mice. While IGFBP2 has little cell-autonomous effect on HSC function, we found decreased in vivo repopulation of HSCs in primary and secondary transplanted IGFBP2-null recipients. Importantly, bone marrow stromal cells that are deficient for IGFBP2 have significantly decreased ability to support the expansion of repopulating HSCs. To investigate the mechanism by which IGFBP2 supports HSC activity, we demonstrated that HSCs in IGFBP2-null mice had decreased survival and cycling, down-regulated expression of antiapoptotic factor Bcl-2, and up-regulated expression of cell cycle inhibitors p21, p16, p19, p57, and PTEN. Moreover, we found that the C-terminus, but not the RGD domain, of extrinsic IGFBP2 was essential for support of HSC activity. Defective signaling of the IGF type I receptor did not rescue the decreased repopulation of HSCs in IGFBP2-null recipients, suggesting that the environmental effect of IGFBP2 on HSCs is independent of IGF-IR mediated signaling. Therefore, as an environmental factor, IGFBP2 supports the survival and cycling of HSCs.

[1]  S. Rafii,et al.  Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells , 2010, Nature Cell Biology.

[2]  M. Waters,et al.  Patched1 Inhibits Epidermal Progenitor Cell Expansion and Basal Cell Carcinoma Formation by Limiting Igfbp2 Activity , 2010, Cancer Prevention Research.

[3]  J. Krosl,et al.  A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. , 2010, Blood.

[4]  Cheng Cheng Zhang,et al.  The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. , 2010, Cell stem cell.

[5]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[6]  Biju Parekkadan,et al.  Mesenchymal stem cells as therapeutics. , 2010, Annual review of biomedical engineering.

[7]  I. Oh,et al.  Concise Review: Multiple Niches for Hematopoietic Stem Cell Regulations , 2010, Stem cells.

[8]  Antony Hsieh,et al.  IGFBP2 promotes glioma tumor stem cell expansion and survival. , 2010, Biochemical and biophysical research communications.

[9]  M. Birnbaum,et al.  AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. , 2010, Blood.

[10]  Y. Ishikawa,et al.  Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3. , 2010, The American journal of pathology.

[11]  C. Zhang,et al.  Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. , 2009, Blood.

[12]  R. Silber,et al.  Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells. , 2009, International journal of molecular medicine.

[13]  Kyoung-Chan Park,et al.  Insulin-like growth factor-binding protein contributes to the proliferation of less proliferative cells in forming skin equivalents. , 2009, Tissue engineering. Part A.

[14]  G. Daley,et al.  Bone marrow adipocytes as negative regulators of the hematopoietic microenvironment , 2009, Nature.

[15]  A. Hoeflich,et al.  Defined carboxy-terminal fragments of insulin-like growth factor (IGF) binding protein-2 exert similar mitogenic activity on cultured rat growth plate chondrocytes as IGF-I. , 2008, Endocrinology.

[16]  H. Lodish,et al.  Cytokines regulating hematopoietic stem cell function , 2008, Current opinion in hematology.

[17]  I. Komuro,et al.  IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis , 2008, Nature.

[18]  H. Lodish,et al.  Insulin‐Like Growth Factor‐Binding Protein 2 Secreted by a Tumorigenic Cell Line Supports Ex Vivo Expansion of Mouse Hematopoietic Stem Cells , 2008, Stem cells.

[19]  M. Bouxsein,et al.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. , 2008, Endocrinology.

[20]  H. Lodish,et al.  Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. , 2008, Blood.

[21]  D. Scadden,et al.  Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. , 2008, Cell stem cell.

[22]  Göran Karlsson,et al.  Signaling pathways governing stem-cell fate. , 2008, Blood.

[23]  D. Steinbach,et al.  Expression of components of the IGF axis in childhood acute myelogenous leukemia , 2008, Pediatric blood & cancer.

[24]  Y. Hayashi,et al.  Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents. , 2007, Cancer research.

[25]  C. Perks,et al.  IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells , 2007, Oncogene.

[26]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 promotes glioma development and progression , 2007, Proceedings of the National Academy of Sciences.

[27]  T. Enver,et al.  NOV (CCN3) Functions as a Regulator of Human Hematopoietic Stem or Progenitor Cells , 2007, Science.

[28]  Antonio Vidal-Puig,et al.  IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance , 2007, Diabetes.

[29]  G. Fuller,et al.  An Interaction between Insulin-like Growth Factor-binding Protein 2 (IGFBP2) and Integrin α5 Is Essential for IGFBP2-induced Cell Mobility* , 2006, Journal of Biological Chemistry.

[30]  B. Gruhn,et al.  Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML , 2006, Bone Marrow Transplantation.

[31]  S. Rosenzweig,et al.  Insulin-Like Growth Factor Binding Protein-2: Contributions of the C-Terminal Domain to Insulin-Like Growth Factor-1 Binding , 2006, Molecular Pharmacology.

[32]  S. Chakrabarty,et al.  Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells , 2006, Cancer biology & therapy.

[33]  H. Lodish,et al.  Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells , 2006, Nature Medicine.

[34]  A. Suminoe,et al.  IDENTIFICATION OF NOVEL GENES WITH PROGNOSTIC VALUE IN CHILDHOOD LEUKEMIA USING cDNA MICROARRAY AND QUANTITATIVE RT-PCR , 2006, Pediatric hematology and oncology.

[35]  A. Hoeflich,et al.  Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. , 2005, Endocrinology.

[36]  H. Lodish,et al.  Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. , 2005, Blood.

[37]  W. Blum,et al.  Insulin-like growth factor binding protein-2 at diagnosis of childhood acute lymphoblastic leukemia and the prediction of relapse risk. , 2005, The Journal of clinical endocrinology and metabolism.

[38]  P. J. Schlueter,et al.  Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos. , 2005, Molecular endocrinology.

[39]  M. Elmlinger,et al.  Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. , 2004, Journal of molecular endocrinology.

[40]  H. Lodish,et al.  Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. , 2004, Blood.

[41]  Joseph J. Pereira,et al.  Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth 1 , 2004, Cancer Research.

[42]  F. Zintl,et al.  Changes of serum growth factors (IGF-I,-II and IGFBP-2,-3) prior to and after stem cell transplantation in children with acute leukemia , 2003, Bone Marrow Transplantation.

[43]  P. Cohen,et al.  Novel stimulatory role for insulin‐like growth factor binding protein‐2 in prostate cancer cells , 2003, International journal of cancer.

[44]  Martin Holzenberger,et al.  IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.

[45]  A. Hoeflich,et al.  Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP‐2 in vivo , 2002, FEBS letters.

[46]  A. Hoeflich,et al.  Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? , 2001, Cancer research.

[47]  E. Nabeyrat,et al.  Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. , 2001, Biochimica et biophysica acta.

[48]  T. Wood,et al.  Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. , 2000, Molecular endocrinology.

[49]  Y. Higami,et al.  Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma. , 1995, Human pathology.

[50]  B. Moats-Staats,et al.  Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. , 1994, Endocrinology.

[51]  M. Elmlinger,et al.  Functional role of insulin-like growth factor binding proteins. , 1997, Hormone research.